Speed Of Coronavirus Vaccine Development May Hurt Public Confidence
Executive Summary
Vaccine developers worry that the focus on development speed may embolden anti-vaccine movement and hurt public willingness to get a COVID-19 shot if one is approved.
You may also be interested in...
COVID-19 Vaccine Distribution Confusion Grows As Eligibility Widens
President-Elect Biden also adds David Kessler and Andy Slavitt to his COVID-19 response team, retains Francis Collins at NIH director.
Trump’s Last-Minute Push for Faster COVID-19 Vaccine Could Jeopardize Uptake
White House and HHS are increasing pressure on FDA Commissioner Hahn to clear Pfizer and Moderna’s COVID-19 vaccines as soon as possible – potentially skirting the advisory committee process. The move is leaving a last-minute political stain on a regulatory process the FDA fought hard to keep science-based and could foster a new wave of vaccine hesitancy amongst the American public.
Biden's COVID-19 Advisory Board Bodes Well For Science-Driven FDA
Two prominent former US FDA officials are a part of the president-elect’s new COVID-19 advisory board. Biden’s emphasis on scientific independence, including a commitment to publicly release vaccine trial data, could help restore public confidence in the agency and coming COVID-19 vaccines.